CLINICAL_TRIALS
trial_result
· 2019-12-12
Clinical Trial Update: Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma [Phase 2]
Summary
Phase 2 clinical trial update for axitinib in unresectable hepatocellular carcinoma has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Health Network, Toronto | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED